DOW INC. DL-,01/ US2605571031 /
2024-05-23 8:01:38 AM | Chg. -0.060 | Volume | Bid6:33:06 PM | Ask6:33:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
53.180EUR | -0.11% | - Turnover: - |
52.750Bid Size: 5,000 | 53.160Ask Size: 5,000 | 37.19 bill.EUR | - | - |
GlobeNewswire
02-13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
01-22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
2023-11-16
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
2023-10-11
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
2023-09-06
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
2021-11-17
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year